1-4 of 4
Ron H.N. van Schaik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform

Free
Anne-Joy M. de Graan, Laure Elens, Marcel Smid, John W. Martens, Alex Sparreboom, Annemieke J.M. Nieuweboer, Lena E. Friberg, Samira Elbouazzaoui, Erik A.C. Wiemer, Bronno van der Holt, Jaap Verweij, Ron H.N. van Schaik, Ron H.J. Mathijssen
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (18): 5210–5217.
https://doi.org/10.1158/1078-0432.CCR-13-0487
Published: 16 September 2013
View articletitled, A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform
Open the PDF for A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform in another window
Journal Articles

CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity

Free
Anne-Joy M. de Graan, Laure Elens, Jason A. Sprowl, Alex Sparreboom, Lena E. Friberg, Bronno van der Holt, Pleun J. de Raaf, Peter de Bruijn, Frederike K. Engels, Ferry A.L.M. Eskens, Erik A.C. Wiemer, Jaap Verweij, Ron H.J. Mathijssen, Ron H.N. van Schaik
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (12): 3316–3324.
https://doi.org/10.1158/1078-0432.CCR-12-3786
Published: 13 June 2013
View articletitled, CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity
Open the PDF for CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity in another window
Includes: Supplementary data
Journal Articles

Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients

Free
Erin R. Lepper, Sharyn D. Baker, Matt Permenter, Nicole Ries, Ron H.N. van Schaik, Paul W. Schenk, Douglas K. Price, Danielle Ahn, Nicola F. Smith, George Cusatis, Roxann G. Ingersoll, Susan E. Bates, Ron H.J. Mathijssen, Jaap Verweij, William D. Figg, Alex Sparreboom
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (20): 7398–7404.
https://doi.org/10.1158/1078-0432.CCR-05-0520
Published: 20 October 2005
View articletitled, Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients
Open the PDF for Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients in another window
Journal Articles

Phase I Pharmacokinetic, Food Effect, and Pharmacogenetic Study of Oral Irinotecan Given as Semisolid Matrix Capsules in Patients with Solid Tumors

Free
Otto Soepenberg, Herlinde Dumez, Jaap Verweij, Floris A. de Jong, Maja J.A. de Jonge, José Thomas, Ferry A.L.M. Eskens, Ron H.N. van Schaik, Johan Selleslach, Judith ter Steeg, Patricia Lefebvre, Sylvie Assadourian, Ger-Jan Sanderink, Alex Sparreboom, Allan T. van Oosterom
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1504–1511.
https://doi.org/10.1158/1078-0432.CCR-04-1758
Published: 02 March 2005
View articletitled, Phase I Pharmacokinetic, Food Effect, and Pharmacogenetic Study of Oral Irinotecan Given as Semisolid Matrix Capsules in Patients with Solid Tumors
Open the PDF for Phase I Pharmacokinetic, Food Effect, and Pharmacogenetic Study of Oral Irinotecan Given as Semisolid Matrix Capsules in Patients with Solid Tumors in another window